SSY Quote, Financials, Valuation and Earnings

CTT Pharmaceutical Holdings has a net margin of -16.93% compared to SunLink Health Systems's net margin of --. SunLink Health Systems's return on equity of 7.13% beat CTT Pharmaceutical Holdings's return on equity of --.

SunLink Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand CTT Pharmaceutical Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that SunLink Health Systems has higher upside potential than CTT Pharmaceutical Holdings, analysts believe SunLink Health Systems is more attractive than CTT Pharmaceutical Holdings.

SunLink Health Systems has a beta of 1.220, which suggesting that the stock is 21.993% more volatile than S&P 500. In comparison CTT Pharmaceutical Holdings has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.71%.

SunLink Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CTT Pharmaceutical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SunLink Health Systems pays -- of its earnings as a dividend. CTT Pharmaceutical Holdings pays out -- of its earnings as a dividend.

SunLink Health Systems quarterly revenues are $7.9M, which are larger than CTT Pharmaceutical Holdings quarterly revenues of --. SunLink Health Systems's net income of -$1.3M is higher than CTT Pharmaceutical Holdings's net income of --. Notably, SunLink Health Systems's price-to-earnings ratio is 6.72x while CTT Pharmaceutical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SunLink Health Systems is 0.21x versus -- for CTT Pharmaceutical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Synergy CHC has a net margin of -16.93% compared to SunLink Health Systems's net margin of --. SunLink Health Systems's return on equity of 7.13% beat Synergy CHC's return on equity of --.

SunLink Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that SunLink Health Systems has higher upside potential than Synergy CHC, analysts believe SunLink Health Systems is more attractive than Synergy CHC.

SunLink Health Systems has a beta of 1.220, which suggesting that the stock is 21.993% more volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

SunLink Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SunLink Health Systems pays -- of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.

SunLink Health Systems quarterly revenues are $7.9M, which are larger than Synergy CHC quarterly revenues of --. SunLink Health Systems's net income of -$1.3M is higher than Synergy CHC's net income of --. Notably, SunLink Health Systems's price-to-earnings ratio is 6.72x while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SunLink Health Systems is 0.21x versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.

Walgreens Boots Alliance has a net margin of -16.93% compared to SunLink Health Systems's net margin of -7.39%. SunLink Health Systems's return on equity of 7.13% beat Walgreens Boots Alliance's return on equity of -46.98%.

SunLink Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand Walgreens Boots Alliance has an analysts' consensus of $12.29 which suggests that it could grow by 14.99%. Given that Walgreens Boots Alliance has higher upside potential than SunLink Health Systems, analysts believe Walgreens Boots Alliance is more attractive than SunLink Health Systems.

SunLink Health Systems has a beta of 1.220, which suggesting that the stock is 21.993% more volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.877%.

SunLink Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 9.36% to investors and pays a quarterly dividend of $0.25 per share. SunLink Health Systems pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

SunLink Health Systems quarterly revenues are $7.9M, which are smaller than Walgreens Boots Alliance quarterly revenues of $38.6B. SunLink Health Systems's net income of -$1.3M is higher than Walgreens Boots Alliance's net income of -$2.9B. Notably, SunLink Health Systems's price-to-earnings ratio is 6.72x while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SunLink Health Systems is 0.21x versus 0.06x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.